Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank
Frontiers in Cardiovascular Medicine · 23.06.2026 · 13
DOI: 10.3389/fcvm.2026.1829003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 23.06.2026. Verfasst von Ting Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Hengyang Medical College, University of South China, Hengyang, Hunan, China. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although pulse pressure (PP) predicts individual cardiometabolic diseases (CMDs), its role in the progression of cardiometabolic multimorbidity (CMM) remains uncertain. This study aimed to investigate the association between PP and CMD progression, from incident CMD to CMM development and all-cause mortality.
Methods
UK Biobank participants ( N = 403,851) were prospectively assessed. PP was evaluated per 1-standard-deviation (SD) increase and across quartiles (Q1–Q4) using Cox proportional hazards models for associations with: (1) incident CMD, (2) progression to CMM (defined as two or more of type 2 diabetes, coronary heart disease, or stroke), and (3) all-cause mortality. Restricted cubic splines were used to examine nonlinearity, and threshold effects were identified using piecewise regression. Competing-risk analyses (Fine-Gray models) and sensitivity analyses excluding the first 2 years of follow-up were performed to address mortality-related competing events and potential reverse causality, respectively. Subgroup analyses were stratified by age, sex, and body mass index (BMI).
Results
Among 403,851 UK Biobank participants who were free of CMD at baseline, per 1-SD increase in PP was significantly associated with transitions from health to CMD (HR = 1.13, 95% CI: 1.12–1.14) and to CMM (HR = 1.18, 95% CI: 1.15–1.21), with Q4 versus Q1 comparisons indicating 36% higher risks for both outcomes. Notably, the PP–CMM association was strongest among patients with stroke, with an HR of 1.23 (95% CI: 1.11–1.36) per 1-SD increase. Subgroup analyses further showed that this association was most pronounced in participants aged < 60 years, women, and those with BMI 18.5 ≤ 25 kg/m 2 . Threshold-effect analyses identified specific risk turning points: 40 mmHg for incident CMD, 42 mmHg for mortality, and 52 mmHg for CMM development among healthy participants, and 57 mmHg for mortality among participants with established CMM.
Conclusion
Our study demonstrates that elevated PP is significantly associated with higher risks of CMD progression and mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, Hengyang Medical College, University of South China, Hengyang, Hunan, China.
- The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China.
- Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Center for Disease Control and Prevention of Mayang, Huaihua, Hunan, China.
Zitieren
APA
Lin, T., Hu, S., Gong, W., Li, L., Zhu, Z., Xie, H., & Zhao, F. (2026). Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1829003
Vancouver
Lin T, Hu S, Gong W, Li L, Zhu Z, Xie H, et al. Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1829003
BibTeX
@article{Lin2026,
author = {Lin, Ting and Hu, Shuai and Gong, Wen and Li, Linqi and Zhu, Zhaowei and Xie, Hebin and Zhao, Feijun},
title = {Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1829003}
}
EUVIMED